A Rare Complication of Chylous Leakage After Open Partial Nephrectomy Successfully Resolved by Somatostatin Analogue by Minoru Kobayashi, Tsunehito Kambara, Takao Kamai

Subjects: Get full text

Long action somatostatin analogues in patients with TSH-secreted pituitary adenomas: treatment experience by L. K. Dzeranova, A. S. Shutova, E. A. Pigarova, P. A. Starostina, N. A. Khutsishvili, S. Yu. Vorotnikova, A. Yu. Grigoriev, O. V. Ivashchenko, V. N. Azyan, A. M. Lapshina

Subjects: Get full text

Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation by Christiaan F. Mooij, Carline E. Tacke, Mirjam E. van Albada, Winfried Barthlen, Hennie Bikker, Klaus Mohnike, Matthijs W.N. Oomen, A.S. Paul van Trotsenburg, Nitash Zwaveling-Soonawala

Subjects: Get full text

The Use of Lanreotide Autogel® in the Treatment of Intestinal Obstruction in a Patient with Adenocarcinoma by Willem Lybaert

Subjects: Get full text

Thyrotropinoma - the case report about one of the rarest type of pituitary adenomas by Piotr Michał Jarosz, Zuzanna Idzik, Jakub Gołacki, Ewa Obel

Subjects: Get full text

Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naïve active acromegaly by Jan-Shun Chang, Ham-Min Tseng, Tien-Chun Chang

Subjects: Get full text

Somatostatine analogue in nonoperative treatment of posttraumatic pancreatic pseudocyst in a child: a case report by Marjanovic Vesna, Slavkovic Andjelka, Stojanovic Miroslav, Stefanovic Vladisav, Marjanovic Goran, Jankovic Radmilo

Subjects: Get full text

Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist by Pooja Dasgupta, Thomas Gűnther, Stefan Schulz

Subjects: Get full text

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide by Beata Kos-Kudła, Jarosław Ćwikła, Marek Ruchała, Alicja Hubalewska-Dydejczyk, Barbara Jarzab, Jolanta Krajewska, Grzegorz Kamiński

Subjects: Get full text

Primary Neuroendocrine Tumor of the Testis and Osseous, Cardiac, and Lymph Node Metastases in a Young Patient by Matthias Penke

Subjects: Get full text

Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results‐Medicare ana... by Katherine Ni, Jeong Yun Yang, Kiwoon Baeg, Amanda C. Leiter, Grace Mhango, Emily J. Gallagher, Juan P. Wisnivesky, Michelle K. Kim

Subjects: Get full text

Quantitative and qualitative assessment of a pituitary neuroendocrine tumor’s T2-signal intensity in acromegaly – a call for unification by Magdalena Godlewska-Nowak, Magdalena Godlewska-Nowak, Anna Grochowska, Grzegorz Zieliński, Anna Bogusławska, Dariusz Adamek, Maria Maksymowicz, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Subjects: Get full text

Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism by Heike Corda, Sebastian Kummer, Alena Welters, Norbert Teig, Dirk Klee, Ertan Mayatepek, Thomas Meissner

Subjects: Get full text

Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel by Gema Marín Zafra, Pedro Segura Luque

Subjects: Get full text

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives by Yau H, Kinaan M, Quinn SL, Moraitis AG

Subjects: Get full text

Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours by Halfdan Sorbye, Liv Sylvi Meyer, Kjersti Elisabeth Mordal, Simen Myhre, Espen Thiis-Evensen

Subjects: Get full text

Outcomes of patients with metastatic neuroendocrine lung neoplasms: typical versus atypical carcinoids by Hugo Tanaka, Marcelo Petrocchi Corassa, Helano Freitas, Milton Barros, Rachel Riechelmann

Subjects: Get full text

Development and Validation of an LC-MS/MS Method for Simultaneous Determination of Short Peptide-Based Drugs in Human Blood Plasma by Elizaveta N. Fisher, Evgeny S. Melnikov, Vladimir Gegeckori, Natalya V. Potoldykova, Dmitry V. Enikeev, Kirill A. Pavlenko, Snezana Agatonovic-Kustrin, David W. Morton, Galina V. Ramenskaya

Subjects: Get full text

Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study by Nicoletta Ranallo, Andrea Roncadori, Nicola Gentili, William Balzi, Mattia Altini, Virginia Ghini, Roberta Maltoni, Alice Andalò, Martina Cavallucci, Maddalena Sansovini, Valentina Fausti, Maria Teresa Montella, Ilaria Massa, Valentina Danesi

Subjects: Get full text

Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues by Manwar A. Mohammed AL-Naqqash

Subjects: “…neuroendocrine tumors, chromogranin A, somatostatin analogues.…”
Get full text